Rheinmetall's Broker Divide: Strong Quarter, Shaky Visibility
Published on 11/05/2026 at 09:51 | Editorial boerse-global.de
Rheinmetall shares changed hands at €850.90 as a fresh round of broker revisions collided with the group's own downgraded guidance, leaving investors to weigh a genuinely stronger operating performance against a planning horizon that has suddenly turned hazy.
JPMorgan's David Perry cut his price target to €1,150 from €1,350 while keeping a "Neutral" rating, a combination that offers little comfort: the lower valuation does not come with a sell recommendation, but neither does the unchanged stance signal the all-clear. Perry continues to flag near-term negative catalysts, and his doubts extend well past the current fiscal year — he expects Rheinmetall to revise its 2030 targets before its capital markets day. That is an analyst's expectation, not a company announcement, and should not be read as a further guidance cut already in the bag.
Guidance Trimmed on Timing, Not Lost Business
The trigger for the reassessment came a day earlier, when Rheinmetall reduced its 2026 revenue forecast to roughly €13.2bn from a previous range of €13.7–14.2bn. Management pointed to likely delays in commissioning the Boxer-based Arminius project and in lot acceptances for artillery ammunition. The expected operating margin was also trimmed, to around 18.5% from roughly 19%, with artillery ammunition revenue shifting into 2027 on the company's own account.
Those are timing effects, not a permanent disappearance of the revenue in question. Still, for valuation purposes the question of when expected orders and acceptances actually convert into sales remains decisive.
Should investors sell immediately? Or is it worth buying Rheinmetall?
Two Bulls, Different Reasons
Not every house moved in the same direction. RBC's Colin Moody reaffirmed an "Outperform" rating with a €1,600 target, arguing that the revised annual goals sit about 8% below consensus at the EBITA line. With the stock trading at a valuation discount of well over 50% to the sector, he contends the disappointment may already be priced in — a valuation thesis rather than an operational all-clear. Moody also continues to see tailwinds from European rearmament, though that long-term driver does not by itself answer when business opportunities become booked revenue and available cash.
Jefferies, too, stuck with its buy recommendation and a €1,350 target. Analyst Chloe Lemarie conceded that the scale of the guidance cut came as a surprise. That pairing is telling: conviction intact even as execution lands worse than expected. Long-term confidence and short-term damaged predictability belong together, not in isolation.
The Quarter Makes the Bull Case — Partly
The operating record offers a genuine counterweight to any blanket narrative of weakness. For the third quarter of 2026, Rheinmetall reported revenue of €3.149bn and an operating result of €553m, up 62% year on year. The operating margin reached 17.5%, compared with 14.8% in the prior-year quarter.
Profitability is improving, not merely earnings — and that gives the optimistic broker views a concrete foundation. The caveat stands nonetheless: a better quarterly margin is no substitute for reliable planning on order closings and acceptances.
Cash Conversion Is Where the Story Tightens
Liquidity is the sticking point. Operating free cash flow in the third quarter of 2026 was minus €82m, an improvement on minus €168m a year earlier, but still negative — which is precisely why operating profit alone cannot carry a valuation. Rheinmetall continues to expect positive operating free cash flow for the full year, yet it has withdrawn its previous target of a cash conversion rate above 40%.
Rheinmetall at a turning point? This analysis reveals what investors need to know now.
Behind that sits timing uncertainty. According to Reuters, no Arminius-Boxer order is now expected this year, pushing revenue and advance payments into the following year. Slower lot acceptances for artillery ammunition add to the drag, and not all revenue opportunities tied to Destinus are likely to materialise in the current year.
November 27 as the Reckoning
Hamburg hosts the capital markets day on 27 November, where, per JPMorgan, the long-term corporate targets will be in focus. Until then, attention centres on how Rheinmetall separates near-term delays from its longer-range plan.
The pressure of the past two days is more specific than a simple continuation of share-price losses: JPMorgan has set a lower valuation marker after the profit warning and dangled the prospect of further target revisions. The distinction that matters is between guidance already cut and additional risks that remain, for now, one analyst's call. Rheinmetall does not need to prove operating strength — the quarterly figures already do that. What is demanded is more dependable conversion into revenue and cash. Until that arrives, the "cheaper valuation" argument persuades less than demonstrable progress on predictability.
Ad
Rheinmetall Stock: New Analysis - 5 November
Fresh Rheinmetall information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
